Reaction
Application Site Mass reporting signals
As of the last recalculation, Application Site Mass appears in 274 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is GRANISETRON (PRR 52.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Granisetron | 7 | 52.0 | 52.0 |
| Pegfilgrastim | 35 | 30.7 | 30.8 |
| Evolocumab | 27 | 13.9 | 13.9 |